Soleno Therapeutics (NASDAQ:SLNO) Hits New 1-Year High on Analyst Upgrade
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday after Laidlaw raised their price target on the stock from $75.00 to $105.00. Laidlaw currently has a buy rating on the stock. Soleno Therapeutics traded as high as $70.20 and last traded at $67.31, with […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday after Laidlaw raised their price target on the stock from $75.00 to $105.00. Laidlaw currently has a buy rating on the stock. Soleno Therapeutics traded as high as $70.20 and last traded at $67.31, with […]
